ES2090121T3 - Modulacion de la respuesta del adenilato ciclasa. - Google Patents

Modulacion de la respuesta del adenilato ciclasa.

Info

Publication number
ES2090121T3
ES2090121T3 ES90901474T ES90901474T ES2090121T3 ES 2090121 T3 ES2090121 T3 ES 2090121T3 ES 90901474 T ES90901474 T ES 90901474T ES 90901474 T ES90901474 T ES 90901474T ES 2090121 T3 ES2090121 T3 ES 2090121T3
Authority
ES
Spain
Prior art keywords
silicic acid
adenylate
modulation
response
ciclasa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90901474T
Other languages
English (en)
Inventor
Karl E Wiegand
Robert K Rude
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethyl Corp
Original Assignee
Ethyl Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethyl Corp filed Critical Ethyl Corp
Application granted granted Critical
Publication of ES2090121T3 publication Critical patent/ES2090121T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Stabilization Of Oscillater, Synchronisation, Frequency Synthesizers (AREA)
  • Steroid Compounds (AREA)

Abstract

EL ACIDO SILICICO MODULA (ES DECIR, AUMENTA O INHIBE) LA ACTIVIDAD DE CICLASA DE ADENILATO. ESTE PARECE SER GENERAL, PUESTO QUE LA MODULACION HA OCURRIDO EN TODOS LOS TEJIDOS ESTUDIADOS. LOS RESULTADOS SUGIEREN QUE EL ACIDO SILICICO PUEDE UTILIZARSE EN MEDICINA HUMANA Y VETERINARIA PARA MODULAR LA RESPUESTA DE HORMONA Y NEUROTRANSMISOR. LOS RESULTADOS TAMBIEN INDICAN QUE EL ACIDO SILICICO PUEDE UTILIZARSE PARA PREVENIR, TRATAR O RETRASAR EL COMIENZO DE ENFERMEDADES OSEAS RELACIONADAS CON EL CALCIO, O PARA MEJORAR LA RESISTENCIA OSEA DE UN VERTEBRADO CON UNA RESISTENCIA OSEA MENOR DE LA DESEADA.
ES90901474T 1988-12-27 1989-12-22 Modulacion de la respuesta del adenilato ciclasa. Expired - Lifetime ES2090121T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/290,307 US4954448A (en) 1988-12-27 1988-12-27 Modulation of adenylate cyclase response

Publications (1)

Publication Number Publication Date
ES2090121T3 true ES2090121T3 (es) 1996-10-16

Family

ID=23115404

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90901474T Expired - Lifetime ES2090121T3 (es) 1988-12-27 1989-12-22 Modulacion de la respuesta del adenilato ciclasa.

Country Status (10)

Country Link
US (1) US4954448A (es)
EP (1) EP0451203B1 (es)
JP (1) JP2960962B2 (es)
KR (1) KR0133729B1 (es)
AT (1) ATE139119T1 (es)
AU (1) AU630143B2 (es)
CA (1) CA1336066C (es)
DE (1) DE68926682T2 (es)
ES (1) ES2090121T3 (es)
WO (1) WO1990007574A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5183061A (en) * 1988-07-22 1993-02-02 Ethyl Corporation Silicon compounds in bone treatment
US5122603A (en) * 1989-03-08 1992-06-16 The University Of Virginia Alumni Patents Foundation Purified insulin mediators and purification process for same
DE69510694T2 (de) * 1994-12-21 1999-10-21 Zeneca Ltd., London Verfahren zum pfropfen
GB0504657D0 (en) * 2005-03-05 2005-04-13 Psimedica Ltd Compositions and methods of treatment
JP5557448B2 (ja) * 2006-09-21 2014-07-23 俊樹 大黒 硬組織再生促進剤
US11490601B2 (en) * 2020-12-23 2022-11-08 X Development Llc Self-calibrating ultrasonic removal of ectoparasites from fish

Also Published As

Publication number Publication date
EP0451203A4 (en) 1991-12-11
CA1336066C (en) 1995-06-27
JP2960962B2 (ja) 1999-10-12
KR910700337A (ko) 1991-03-14
AU630143B2 (en) 1992-10-22
EP0451203A1 (en) 1991-10-16
US4954448A (en) 1990-09-04
JPH04504653A (ja) 1992-08-20
KR0133729B1 (ko) 1998-04-21
DE68926682D1 (de) 1996-07-18
DE68926682T2 (de) 1996-11-28
AU4837390A (en) 1990-08-01
ATE139119T1 (de) 1996-06-15
WO1990007574A1 (en) 1990-07-12
EP0451203B1 (en) 1996-06-12

Similar Documents

Publication Publication Date Title
IT8419266A1 (it) Dispositivo per generare calore in tessuti" del corpo umano e procedimento di cenerazione di calore, particolarmente per la cura di tumori
IT1202558B (it) Protesi interna per la sostituzione di una parte del corpo umano particolarmente nelle operazioni vascolari
ES2073583T3 (es) Dispositivo para irradiar rayos laser.
ES2001148B3 (es) Conjunto de placa de fijacion osea con hilos de sutura.
ATE97316T1 (de) Kosmetisches mittel und zusammensetzung zur behandlung der haut.
NO921454L (no) Fremgangsmaater og blandinger for heling av ben
ATE112684T1 (de) Verwendung von igf-ii zur behandlung von knochenkrankheiten.
MX9805705A (es) Compuestos biaromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
IL138290A0 (en) Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
KR910700337A (ko) 아데닐레이트 사이클라아제 응답을 변형시키는 방법
AR004494A1 (es) Una celula util para el tratamiento del dolor, un metodo para producirla, un organo bioartificial de la comprende y un metodo para preparar dicho organobioartificial
ATE181668T1 (de) Verwendung von 5-ht4 rezeptorantagonisten zur behandlung von vorhof-fibrillation und zur vorbeugung von schlaganfall
ZA878249B (en) Method and therapeutic compositions for the treatment of bleeding disorders
ES2051687T3 (es) Procedimiento de preparar un gel basico coloidal que contiene pirimicina.
ES2110057T3 (es) Composicion medicinal que contiene tcf-ii.
ES2085199B1 (es) Un procedimiento para la preparacion de una formulacion depot.
ES2044534T3 (es) Un metodo para la preparacion de una composicion tromboliticamente activa.
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
ZA988569B (en) Veterinary medicine containing native or modified equine choriogonadotrophin to induce ovulation in mares and stimulate the production of testosterone in stallions
Carothers Sprained ankles
Kelly Mechanics and treatment of vasovagal syncope
UA29707A (uk) Спосіб відновлення кісткових тканин при переломах
Imrie Unstable fractures of the wrist
Vagin et al. Experiment with the local effect of superhigh-frequency electromagnetic energy on biologically active points
MD1270G2 (ro) Metodă de tratament al pseudoartrozei de scafoid carpian

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 451203

Country of ref document: ES

FG2A Definitive protection

Ref document number: 451203

Country of ref document: ES